These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 29364196)

  • 1. A two-dose hepatitis B vaccine for adults (Heplisav-B).
    Med Lett Drugs Ther; 2018 Jan; 60(1539):17-18. PubMed ID: 29364196
    [No Abstract]   [Full Text] [Related]  

  • 2. Safety and immunogenicity of a modified process hepatitis B vaccine in healthy adults ≥50 years.
    Gilbert CL; Klopfer SO; Martin JC; Schödel FP; Bhuyan PK
    Hum Vaccin; 2011 Dec; 7(12):1336-42. PubMed ID: 22185811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of hepatitis B vaccination using HEPLISAV™ in selected adult populations compared to Engerix-B® vaccine.
    Kuan RK; Janssen R; Heyward W; Bennett S; Nordyke R
    Vaccine; 2013 Aug; 31(37):4024-32. PubMed ID: 23707166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B vaccine: a seven-year study of adherence to the immunization guidelines and efficacy in HIV-1-positive adults.
    Bailey CL; Smith V; Sands M
    Int J Infect Dis; 2008 Nov; 12(6):e77-83. PubMed ID: 18723381
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of four recombinant hepatitis B vaccines applied on an accelerated schedule in healthy adults.
    Hernández-Bernal F; Aguilar-Betancourt A; Aljovin V; Arias G; Valenzuela C; de Alejo KP; Hernández K; Oquendo O; Figueredo N; Figueroa N; Musacchio A; Véliz G; García E; Mollineda AD; Juvier AI; Trujillo J; Delahanty A; Ortega D; Cinza Z; González VL
    Hum Vaccin; 2011 Oct; 7(10):1026-36. PubMed ID: 21941089
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recombivax-HB: perspectives past, present and future.
    Venters C; Graham W; Cassidy W
    Expert Rev Vaccines; 2004 Apr; 3(2):119-29. PubMed ID: 15056038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A three-antigen hepatitis B vaccine (PreHevbrio).
    Med Lett Drugs Ther; 2022 May; 64(1650):73-75. PubMed ID: 35536120
    [No Abstract]   [Full Text] [Related]  

  • 8. Unsolved problems and future perspectives of hepatitis B virus vaccination.
    Tajiri K; Shimizu Y
    World J Gastroenterol; 2015 Jun; 21(23):7074-83. PubMed ID: 26109794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heplisav-B vaccination for the prevention of hepatitis B virus infection in adults in the United States.
    Splawn LM; Bailey CA; Medina JP; Cho JC
    Drugs Today (Barc); 2018 Jul; 54(7):399-405. PubMed ID: 30090877
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatitis B surface antigenemia following recombinant Engerix B hepatitis B vaccine in an 81-year-old ESRD patient on hemodialysis.
    Onuigbo MA; Nesbit A; Weisenbeck J; Hurlburt J
    Ren Fail; 2010 May; 32(4):531-2. PubMed ID: 20446799
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-dose hepatitis B vaccination schedule in travelers presenting for late consultation.
    Wong J; Payne M; Hollenberg S
    J Travel Med; 2014; 21(4):260-5. PubMed ID: 24796543
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatitis B vaccines.
    Wkly Epidemiol Rec; 2009 Oct; 84(40):405-19. PubMed ID: 19817017
    [No Abstract]   [Full Text] [Related]  

  • 13. National advisory committee on immunization (NACI). Statement on hepatitis B vaccine.
    Can Commun Dis Rep; 1993 Jul; 19(14):104-15. PubMed ID: 8364441
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The immunogenicity and safety of GSK's recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience.
    Van Den Ende C; Marano C; Van Ahee A; Bunge EM; De Moerlooze L
    Expert Rev Vaccines; 2017 Aug; 16(8):811-832. PubMed ID: 28573913
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatitis B immunization of adolescents.
    Halsey NA
    Pediatr Infect Dis J; 1995 Dec; 14(12):1124-5. PubMed ID: 8745038
    [No Abstract]   [Full Text] [Related]  

  • 16. A two-dose schedule for combined hepatitis A and B vaccination in children aged 6-15 years.
    Kurugöl Z; Mutlubaş F; Ozacar T
    Vaccine; 2005 Apr; 23(22):2876-80. PubMed ID: 15780736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of a hepatitis B vaccination schedule with two cycles of four double doses of conventional vaccine and four doses of adjuvanted vaccine in chronic kidney disease patients evaluated for renal transplantation.
    García-Agudo R; Aoufi Rabih S; Araque Torres P; Dolores Fraga Fuentes M; Carlos Valenzuela Gámez J; Mancha Ramos J; María Tenías Burillo J
    Transplant Proc; 2012 Nov; 44(9):2532-4. PubMed ID: 23146445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adult immunization against hepatitis B: Does the number of jabs matter?
    Oster G; Bornheimer R; Ottino K; Stevenson C; Lewin C; Janssen R
    Vaccine; 2022 Jun; 40(26):3597-3604. PubMed ID: 35570079
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thiomersal-free and thiomersal-containing formulations of a recombinant hepatitis B vaccine (Hepavax-Gene) in healthy adults.
    Rebedea I; Diaconescu IG; Bach D; Bartelsen O; Arndtz N
    Vaccine; 2006 Jun; 24(25):5320-6. PubMed ID: 16707195
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A randomized clinical trial of immunization with combined hepatitis A and B versus hepatitis B alone for hepatitis B seroprotection in hemodialysis patients.
    Tung J; Carlisle E; Smieja M; Kim PT; Lee CH
    Am J Kidney Dis; 2010 Oct; 56(4):713-9. PubMed ID: 20630640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.